Heart Test Laboratories Inc has a consensus price target of $4.77, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from Ascendiant Capital, Maxim Group, and Maxim Group on January 30, 2023, December 19, 2022, and November 9, 2022. With an average price target of $4.77 between Ascendiant Capital, Maxim Group, and Maxim Group, there's an implied 4605.50% upside for Heart Test Laboratories Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/30/2023 | HSCS | Buy Now | Heart Test Laboratories | $0.10 | 3157.65% | Ascendiant Capital | Edward Woo | → $3.3 | Initiates | → Buy | Get Alert |
12/19/2022 | HSCS | Buy Now | Heart Test Laboratories | $0.10 | 2861.5% | Maxim Group | Allen Klee | $8 → $3 | Maintains | Buy | Get Alert |
11/09/2022 | HSCS | Buy Now | Heart Test Laboratories | $0.10 | 7797.33% | Maxim Group | Allen Klee | → $8 | Initiates | → Buy | Get Alert |
08/08/2022 | HSCS | Buy Now | Heart Test Laboratories | $0.10 | 7797.33% | Benchmark | Bruce Jackson | → $8 | Initiates | → Speculative Buy | Get Alert |
The latest price target for Heart Test Laboratories (NASDAQ: HSCS) was reported by Ascendiant Capital on January 30, 2023. The analyst firm set a price target for $3.30 expecting HSCS to rise to within 12 months (a possible 3157.65% upside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Heart Test Laboratories (NASDAQ: HSCS) was provided by Ascendiant Capital, and Heart Test Laboratories initiated their buy rating.
There is no last upgrade for Heart Test Laboratories.
There is no last downgrade for Heart Test Laboratories.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Heart Test Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Heart Test Laboratories was filed on January 30, 2023 so you should expect the next rating to be made available sometime around January 30, 2024.
While ratings are subjective and will change, the latest Heart Test Laboratories (HSCS) rating was a initiated with a price target of $0.00 to $3.30. The current price Heart Test Laboratories (HSCS) is trading at is $0.10, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.